Archive for September, 2007

US FDA issues 'not approvable' letter for Vernalis Frova new … - Hemscott

US FDA issues 'not approvable' letter for Vernalis Frova new …Hemscott, UK - 43 minutes agoThe FDA questioned whether trial results were really clinically significant for menstrual migraine, although it noted more headache-free days with the …
Original post by FDA "pain relief" pharmaceutical - Google News

Market Report — In Play (ENDP) - MSN Money

Market Report — In Play (ENDP)MSN Money - 2 hours ago… the number of headache-free perimenstrual periods (PMPs), it questioned whether the benefit demonstrated was clinically meaningful. The FDA also noted …
Original post by FDA "pain relief" pharmaceutical - Google News

Obesity and eating healthy foods top the list of health issues - SpiritIndia

Obesity and eating healthy foods top the list of health issuesSpiritIndia, India - 27 minutes agoMen who smoke risk erectile dysfunction — Otherwise healthy men who smoke risk developing erectile dysfunction ? and the more cigarettes they smoke, …
Original post by FDA "pain relief" pharmaceutical - Google News

FDA approves Afluria in time for flu season - News-Medical.net

FDA approves Afluria in time for flu seasonNews-Medical.net, Australia - 1 hour agoThe most commonly reported adverse events were tenderness, pain, redness and swelling at the injection site, and headache, fatigue and muscle aches. …
Original post by FDA "pain relief" pharmaceutical - Google News

US FDA looks for more information on Endo's Frova - Reuters

US FDA looks for more information on Endo's FrovaReuters - 36 minutes agoWhile drug trials met their primary endpoints in significantly improving the number of headache-free perimenstrual periods, the FDA questioned whether the …
Original post by FDA "pain relief" pharmaceutical - Google News

US FDA looks for more information on Endo's Frova - Reuters.uk

US FDA looks for more information on Endo's FrovaReuters.uk, UK - 39 minutes agoWhile drug trials met their primary endpoints in significantly improving the number of headache-free perimenstrual periods, the FDA questioned whether the …
Original post by FDA "pain relief" pharmaceutical - Google News

Endo And Vernalis Says FDA Seeks Additional Info Regarding SNDA … - RTT News

Endo And Vernalis Says FDA Seeks Additional Info Regarding SNDA …RTT News, NY - 23 minutes ago… the number of headache-free perimenstrual periods (PMPs), it questioned whether the benefit demonstrated was clinically meaningful. The FDA also noted …
Original post by FDA "pain relief" pharmaceutical - Google News

Endo, Vernalis set back on new migraine-drug use - MarketWatch

Endo, Vernalis set back on new migraine-drug useMarketWatch - 53 minutes agoThe FDA said that the clinical trials for the drug met their key endpoints by increasing the number of headache-free perimenstrual periods, the companies …
Original post by FDA "pain relief" pharmaceutical - Google News

Suburban drug company devotes energy finding a cure - Chicago Daily Herald

Suburban drug company devotes energy finding a cureChicago Daily Herald, IL - 1 hour agoInc. to market pafuramidine for PCP in the US Immtech received an initial payment of $3 million and will get the rest as the drug advances through the FDA …
Original post by FDA "pain relief" pharmaceutical - Google News

Endo Pharmaceuticals and Vernalis Receive Action Letter From FDA … - Trading Markets

Endo Pharmaceuticals and Vernalis Receive Action Letter From FDA …Trading Markets, CA - 2 hours ago… the number of headache-free perimenstrual periods (PMPs), it questioned whether the benefit demonstrated was clinically meaningful. The FDA also noted …
Original post by FDA "pain relief" pharmaceutical - Google News




 

 



Warning: MagpieRSS: Failed to fetch http://news.google.com/news?hl=en&client=news&ie=ISO-8859-1&tab=bn&scoring=n&q=FDA+%22insomnia%22&output=rs (HTTP Response: HTTP/1.0 404 Not Found ) in /home/content/G/l/o/GlobaIntellect/html/chigbrow/pharmablog/wp-content/plugins/wp-autoblog/rss_fetch.inc on line 237